tegafur has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies
Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two female breast cancer patients who received combined tamoxifen and tegafur as postsurgical adjuvant therapy developed severe hepatotoxicity after being treated for three and eight months, respectively." | 7.69 | Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy. ( Abe, J; Hirayama, C; Maruyama, S; Matsui, K; Tanaka, J, 1995) |
| "Two female breast cancer patients who received combined tamoxifen and tegafur as postsurgical adjuvant therapy developed severe hepatotoxicity after being treated for three and eight months, respectively." | 3.69 | Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy. ( Abe, J; Hirayama, C; Maruyama, S; Matsui, K; Tanaka, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, F | 1 |
| Ikeda, T | 1 |
| Sakamoto, N | 1 |
| Kurosaki, M | 1 |
| Tozuka, S | 1 |
| Sakamoto, S | 1 |
| Fukuma, T | 1 |
| Marumo, F | 1 |
| Sato, C | 1 |
| Maruyama, S | 1 |
| Hirayama, C | 1 |
| Abe, J | 1 |
| Tanaka, J | 1 |
| Matsui, K | 1 |
2 other studies available for tegafur and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Severe chronic active hepatitis induced by UFTR containing tegafur and uracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chemic | 1995 |
Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brea | 1995 |